Literature DB >> 33320246

Regulation of ST6GAL1 sialyltransferase expression in cancer cells.

Kaitlyn A Dorsett1, Michael P Marciel1, Jihye Hwang1, Katherine E Ankenbauer1, Nikita Bhalerao1, Susan L Bellis1.   

Abstract

The ST6GAL1 sialyltransferase, which adds α2-6 linked sialic acids to N-glycosylated proteins, is overexpressed in a wide range of human malignancies. Recent studies have established the importance of ST6GAL1 in promoting tumor cell behaviors such as invasion, resistance to cell stress and chemoresistance. Furthermore, ST6GAL1 activity has been implicated in imparting cancer stem cell characteristics. However, despite the burgeoning interest in the role of ST6GAL1 in the phenotypic features of tumor cells, insufficient attention has been paid to the molecular mechanisms responsible for ST6GAL1 upregulation during neoplastic transformation. Evidence suggests that these mechanisms are multifactorial, encompassing genetic, epigenetic, transcriptional and posttranslational regulation. The purpose of this review is to summarize current knowledge regarding the molecular events that drive enriched ST6GAL1 expression in cancer cells.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ST6GAL1; cancer; gene regulation; sialic acid

Mesh:

Substances:

Year:  2021        PMID: 33320246      PMCID: PMC8176773          DOI: 10.1093/glycob/cwaa110

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  132 in total

Review 1.  Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.

Authors:  Naoyuki Taniguchi; Yasuhiko Kizuka
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

2.  Enzymic control of the expression of the X determinant (CD15) in human myeloid cells during maturation: the regulatory role of 6-sialytransferase.

Authors:  P O Skacel; A J Edwards; C T Harrison; W M Watkins
Journal:  Blood       Date:  1991-09-15       Impact factor: 22.113

3.  Integrated analysis of high-resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patients.

Authors:  Thomas Fleischer; Hege Edvardsen; Hiroko K Solvang; Christian Daviaud; Bjørn Naume; Anne-Lise Børresen-Dale; Vessela N Kristensen; Jörg Tost
Journal:  Int J Cancer       Date:  2014-01-06       Impact factor: 7.396

4.  Increased CMP-NeuAc:Gal beta 1,4GlcNAc-R alpha 2,6 sialyltransferase activity in human colorectal cancer tissues.

Authors:  F Dall'Olio; N Malagolini; G di Stefano; F Minni; D Marrano; F Serafini-Cessi
Journal:  Int J Cancer       Date:  1989-09-15       Impact factor: 7.396

5.  Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility.

Authors:  Eric C Seales; Gustavo A Jurado; Brian A Brunson; John K Wakefield; Andra R Frost; Susan L Bellis
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

6.  Phenotypic changes induced by expression of beta-galactoside alpha2,6 sialyltransferase I in the human colon cancer cell line SW948.

Authors:  Mariella Chiricolo; Nadia Malagolini; Silvia Bonfiglioli; Fabio Dall'Olio
Journal:  Glycobiology       Date:  2005-09-28       Impact factor: 4.313

7.  The Inhibitory Role of α2,6-Sialylation in Adipogenesis.

Authors:  Tomoko Kaburagi; Yasuhiko Kizuka; Shinobu Kitazume; Naoyuki Taniguchi
Journal:  J Biol Chem       Date:  2016-12-28       Impact factor: 5.157

Review 8.  Regulation of the metastatic cell phenotype by sialylated glycans.

Authors:  Matthew J Schultz; Amanda F Swindall; Susan L Bellis
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

9.  Transfection of 2,6 and 2,3-sialyltransferase genes and GlcNAc-transferase genes into human glioma cell line U-373 MG affects glycoconjugate expression and enhances cell death.

Authors:  G Dawson; J R Moskal; S A Dawson
Journal:  J Neurochem       Date:  2004-06       Impact factor: 5.372

10.  Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cells.

Authors:  Colleen M Britain; Nikita Bhalerao; Austin D Silva; Asmi Chakraborty; Donald J Buchsbaum; Michael R Crowley; David K Crossman; Yvonne J K Edwards; Susan L Bellis
Journal:  J Biol Chem       Date:  2020-11-23       Impact factor: 5.157

View more
  13 in total

1.  The incorrect use of CD75 as a synonym for ST6GAL1 has fostered the expansion of commercial "ST6GAL1" antibodies that do not recognize ST6GAL1.

Authors:  Barnita Haldar; Jihye Hwang; Yoshiki Narimatsu; Henrik Clausen; Susan L Bellis
Journal:  Glycobiology       Date:  2022-08-18       Impact factor: 5.954

2.  Extracellular ST6GAL1 regulates monocyte-macrophage development and survival.

Authors:  Michael E Rusiniak; Patrick R Punch; Nitai C Hait; Aparna Maiti; Robert T Burns; Digantkumar Chapla; Kelley W Moremen; Peng Zhao; Lance Wells; Karin Hoffmeister; Joseph T Y Lau
Journal:  Glycobiology       Date:  2022-07-13       Impact factor: 5.954

3.  Extracellular sialyltransferase st6gal1 in breast tumor cell growth and invasiveness.

Authors:  Nitai C Hait; Aparna Maiti; Rongrong Wu; Valerie L Andersen; Chang-Chieh Hsu; Yun Wu; Digantkumar G Chapla; Kazuaki Takabe; Michael E Rusiniak; Wiam Bshara; Jianmin Zhang; Kelley W Moremen; Joseph T Y Lau
Journal:  Cancer Gene Ther       Date:  2022-06-08       Impact factor: 5.854

4.  Applying transcriptomics to studyglycosylation at the cell type level.

Authors:  Leo Alexander Dworkin; Henrik Clausen; Hiren Jitendra Joshi
Journal:  iScience       Date:  2022-05-18

Review 5.  Bridging Glycomics and Genomics: New Uses of Functional Genetics in the Study of Cellular Glycosylation.

Authors:  Natalie Stewart; Simon Wisnovsky
Journal:  Front Mol Biosci       Date:  2022-06-16

Review 6.  What is the Sugar Code?

Authors:  Hans-Joachim Gabius; Maré Cudic; Tammo Diercks; Herbert Kaltner; Jürgen Kopitz; Kevin H Mayo; Paul V Murphy; Stefan Oscarson; René Roy; Andreas Schedlbauer; Stefan Toegel; Antonio Romero
Journal:  Chembiochem       Date:  2021-09-22       Impact factor: 3.461

Review 7.  Abnormal sialylation and fucosylation of saliva glycoproteins: Characteristics of lung cancer-specific biomarkers.

Authors:  Ziyuan Gao; Mingming Xu; Shuang Yue; Huang Shan; Jun Xia; Junhong Jiang; Shuang Yang
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-12-20

8.  Abnormal Expression and Prognosis Value of COG Complex Members in Kidney Renal Clear Cell Carcinoma (KIRC).

Authors:  Yanjun Zhang; Hui Lai; Bin Tang
Journal:  Dis Markers       Date:  2021-09-08       Impact factor: 3.434

Review 9.  ST6Gal1: Oncogenic signaling pathways and targets.

Authors:  Sajina Gc; Susan L Bellis; Anita B Hjelmeland
Journal:  Front Mol Biosci       Date:  2022-08-29

Review 10.  Aberrant Sialylation in Cancer: Therapeutic Opportunities.

Authors:  Jennifer Munkley
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.